HIV/AIDS INFORMATION CENTER

News

FDA: Possible Risk of Neural Tube Birth Defects With Certain HIV Meds

FDA: Possible Risk of Neural Tube Birth Defects With Certain HIV Meds

The Agency has received reports of serious neural tube birth defects involving the brain, spine, and spinal cord in babies born to women who received dolutegravir for HIV treatment.

CVS unintentionally reveals HIV status of 6,000 customers, per lawsuit

CVS Health faces lawsuit for revealing the HIV status of 6,000 patients in Ohio.

FDA approves antiretroviral therapy for multidrug-resistant HIV

The FDA has approved Trogarzo for heavily treated adult patients living with HIV and whose HIV infections cannot be successfully treated with other currently available therapies.

Opinion

The origin of AIDS and debating the Patient Zero theory

There is evidence that HIV might have spread from its origins in the US to the rest of the world.

HIV complacency can be deadly

It's been 32 years since the CDC published the first HIV case report, and too many Americans no longer view the disease as a serious illness.

Features

Healthcare issues of the LGBT community: What the primary care clinician should know

Healthcare issues of the LGBT community: What the primary care clinician should know

A greater understanding of the healthcare issues specific to the lesbian, gay, bisexual, and transgender community may improve the quality of care.

Initiating antiretroviral therapy in HIV patients with CD4 T-cell counts >500 cells/mcL

Initiating antiretroviral therapy in HIV patients with CD4 T-cell counts >500 cells/mcL

Recommendations for initiation of antiretroviral therapy (ART) in asymptomatic adults with HIV are generally based on CD4 T-cell counts.

Sign Up for Free e-newsletters